Research Articles | Page 5 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options Jan 2021 Cancer Management and Research Myelodysplastic Syndromes (MDS)
Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience Sep 2020 Leukemia & Lymphoma Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Clonal dynamics of aplastic anemia/paroxysmal nocturnal hemoglobinuria Dec 2019 Leukemia & Lymphoma Aplastic Anemia
Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery? Jun 2023 Leukemia & Lymphoma Aplastic Anemia
Clonal Hematopoiesis and therapy related MDS/AML Mar 2019 Best Practice & Research. Clinical Heamatology Myelodysplastic Syndromes (MDS)
Clonal Hematopoiesis, Inflammation, and Hematologic Malignancy Oct 2023 Annual Review of Pathology: Mechanisms of Disease Aplastic Anemia, Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clonal selection in therapy related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment Jan 2020 European Journal of Haematology Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Complement inhibition in medicine: Hematology and beyond; complement inhibition in hematology: PNH and beyond May 2023 American Journal of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations Jun 2023 Advances in Therapy Paroxysmal Nocturnal Hemoglobinuria (PNH)
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy Jun 2023 Haematologica Aplastic Anemia